NVO gains CHMP backing for a higher-dose Wegovy, paving the way for potential EU approval in 2026 as study data show stronger ...

While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...

A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as ...

The Netherlands launch builds on Biocon's entry into the UK in February, where it received regulatory approval for ...

Pvt. Ltd. v. M/s Speedways Tyre Treads & Anr., CS(COMM) 1155/2025 Gajulapalli Mallikarjuna v. State of Andhra Pradesh, ...

The U.S. Food and Drug Administration said on Monday it ‍has granted a national priority voucher to Johnson & Johnson's blood ...

Emma Kleck has been totally dependent on insulin, the lifesaving medication for people living with diabetes, for 25 years.

Doctors caution that while Ozempic can help manage diabetes and obesity under medical supervision, misuse as a weight-loss ...

In a major milestone for Veeva AI, industry-specific AI for life sciences, Veeva Systems (NYSE: VEEV) today announced the ...

Sanofi sees continued growth and strong financials despite a pipeline setback. Click for this updated look at SNY stock ...